|
KMID : 0363820010350050301
|
|
Korean Journal of Nuclear Medicine
2001 Volume.35 No. 5 p.301 ~ p.312
|
|
|
Findings of F - 18 FDG Whole Body PET in Patients with Stomach Cancer
|
|
Kim Byung-Il
Lee Jong-Inn
Yang Won-Il
Lee Jae-Sung
Cheon Gi-Jeong
Choi Chang-Woon
Lim Sang-Moo
Hong Sung-Woon
|
|
|
Abstract
|
|
|
Purpose: Stomach cancer is one of the most common malignancies in Korea, but there is no report on FDG PET in patients with stomach cancer. We observed findings of FDG PET in patients with stomach cancer.
Materials and Methods: In 13 patients with pre-operative stomach cancer, PET and CT were performed. Primary lesion and regional lymph nodes detection were analyzed. Correlation between FDG uptake ratio and each prognostic factor of primary lesion was analyzed. In 19 patients diagnosed as recurrence or displaying suspicious symptoms, conventional work up including tumor marker and PET were performed. Recurrence detection of anastomotic site, distant metastasis, and tumor marker elevation were analyzed.
Results : Sensitivity for primary lesion detection was 83.3% (CT 71.4%) and two submucosal lesions were undetected. FDG uptake ratio was variable and had no correlation with invasion-depth, size, Borrmann type, staging and differentiation. Sensitivity for regional lymph node detection was 58.3% (CT 58.3%) and the lesions less than 1cm were undetected. Sensitivity for recurrence detection was 100% but there were three false positives. Sensitivity for distant metastasis detection was 64.3% and significantly higher than that of conventional work-up (21.4%). Average of tumor marker level in patients who were confirmed as recurrence was higher than false positive.
Conclusion - PET is more useful than conventional work up in distant metastasis detection when recurrence is suspected. In pre-operative stomach cancer, PET is comparable to CT for detection of primary lesion and regional lymph node metastasis and detection of distant metastasis requires further study.
|
|
|
KEYWORD
|
|
|
Stomach cancer, F - 18 FDG PET, Tumor marker
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|